Capital Allergy & Respiratory Disease Center — Sacramento, California

Capital Allergy & Respiratory Disease Center is a clinical research site located in Sacramento, California, United States 95819.

Crixeo Health Trust Score: 66/100 (FAIR). This profile has not yet been claimed by the site owner.

Capital Allergy & Respiratory Disease Center has participated in 4 clinical trials.

Therapeutic areas: COPD, Primary Immunodeficiency Diseases (PID), Cystic Fibrosis.

Sponsors: Sunovion Respiratory Development Inc., Baxalta now part of Shire, Merck Sharp & Dohme LLC.

Sponsor Feasibility Report

Trust Score: 66/100. Verification status: Not yet accredited. Patient reviews: 0. Complaints: 0.

Frequently Asked Questions

What is the Trust Score for Capital Allergy & Respiratory Disease Center?

Capital Allergy & Respiratory Disease Center has a Crixeo Trust Score of 66/100 (FAIR). Trust Scores reflect trial volume, sponsor diversity, patient reviews, address verification, and accreditation status.

How many clinical trials has Capital Allergy & Respiratory Disease Center conducted?

Capital Allergy & Respiratory Disease Center has 4 clinical trials on record. Their work covers COPD, Primary Immunodeficiency Diseases (PID), Cystic Fibrosis.

Is Capital Allergy & Respiratory Disease Center accredited by Crixeo Health?

Capital Allergy & Respiratory Disease Center has not yet obtained Crixeo Accreditation. Site owners can claim their profile and apply for accreditation to improve visibility with sponsors and patients.

Can I submit a review or complaint about Capital Allergy & Respiratory Disease Center?

Yes. Patients and trial participants can submit reviews and file complaints directly on this profile page. All submissions are reviewed before publication.